Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis

Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis

US Patent 11857541 · Granted Jan 2, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide analogues targeting human LMNA2023
Oligonucleotide analogues targeting human LMNA2020
Methods for treating progeroid laminopathies using oligonucleotide analogues tar2019
Combination therapies for treatment of laminopathies, cellular aging, and athero2018
Combination therapies for treatment of laminopathies, cellular aging, and athero2018
Combination therapies for treatment of laminopathies, cellular aging, and athero2018
Combination therapies for treatment of laminopathies, cellular aging, and athero2016
Combination therapies for treatment of laminopathies, cellular aging, and athero2016
Combination therapies for treatment of laminopathies, cellular aging, and athero2016
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and2015
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging an2014
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging an2014